Urinalysis Market By Product (Instruments, Consumables) , By Application (Disease Screening, Pregnancy & Fertility Testing) By End User (Hospitals, Clinical Laboratories, Home Care) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The urinalysis market was valued at $3.1 billion in 2023, and is projected to reach $6.8 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033.
Urinalysis is a series of test that involves the examination of urine to detect and manage a wide range of disorders, such as urinary tract infections, diabetes, and kidney diseases. It encompasses both physical and chemical examinations of urine, as well as microscopic analysis of its cellular and particulate components. By analyzing the physical, chemical, and microscopic properties of urine, healthcare providers can assess urine color, clarity, and odor, which can provide initial clues about metabolic disorders.
The growth of the global urinalysis market is majorly driven by high incidence of urinary tract infections (UTIs), especially among women and the elderly, and increase in cases of kidney disorders. According to the National Institute of Health—world's foremost medical research centers—the number of UTI cases increased by 60.40% from 252.25 million in 1990 to 404.61 million in 2019, and this number is expected to increase significantly in the coming future. Furthermore, as per a study published in March 2024 by Lancet—one of the world's highest-impact academic journals—more than 850 million individuals are suffering from kidney disease globally. Moreover, alarming rise in prevalence of diabetes necessitate regular urinalysis for early detection and management, which acts as a key driving force of the global market. In addition, surge in geriatric population notably contributes toward the growth of the market. This is attributed to the fact that the aging population is highly susceptible to various urinary and renal conditions, leading to increased utilization of urinalysis in geriatric healthcare. However, high cost associated with urinalysis hampers the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access restrain the market growth. On the contrary, integration of AI and ML in digital urinalysis systems is expected to offer remunerative opportunities for the expansion of the market during the forecast period.
The global urinalysis industry segmented into by product, end user, and region. By product, the market is divided into instruments, and consumables. On the basis of application, it is fragmented into disease screening, and pregnancy & fertility testing. Depending on end user, it is segregated into hospitals, clinical laboratories, and home care. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the consumable segment dominated the market share in 2023.
On the basis of application, the disease screening segment exhibited the highest market share in 2023.
Depending on end user, the clinical laboratories segment was the major shareholder in 2023.
Region wise, the market in North America is anticipated to lead the market by 2033.
Competition Analysis
Competitive analysis and profiles of the major players in the global urinalysis market include Abbott Laboratories, Sysmex Corporation, Siemens Healthcare GmbH, ACON Laboratories, Inc., Arkray Inc, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to capture maximum share and sustain the intense competition.
Key Market Segments
By Product
Instruments
Consumables
By Application
Disease Screening
Pregnancy Fertility Testing
By End User
Hospitals
Clinical Laboratories
Home Care
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories
Sysmex Corporation
Siemens Healthcare GmbH
ACON Laboratories, Inc.
Arkray Inc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
F. Hoffmann-La Roche Ltd.
Quidel Corporation
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: URINALYSIS MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Instruments
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Consumables
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: URINALYSIS MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Disease Screening
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Pregnancy Fertility Testing
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: URINALYSIS MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Clinical Laboratories
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Home Care
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: URINALYSIS MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Urinalysis Market
- 7.2.6.1. Market Size and Forecast, By Product
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Urinalysis Market
- 7.2.7.1. Market Size and Forecast, By Product
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Urinalysis Market
- 7.2.8.1. Market Size and Forecast, By Product
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Urinalysis Market
- 7.3.6.1. Market Size and Forecast, By Product
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Urinalysis Market
- 7.3.7.1. Market Size and Forecast, By Product
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Urinalysis Market
- 7.3.8.1. Market Size and Forecast, By Product
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Urinalysis Market
- 7.3.9.1. Market Size and Forecast, By Product
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Urinalysis Market
- 7.3.10.1. Market Size and Forecast, By Product
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Urinalysis Market
- 7.3.11.1. Market Size and Forecast, By Product
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Urinalysis Market
- 7.4.6.1. Market Size and Forecast, By Product
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Urinalysis Market
- 7.4.7.1. Market Size and Forecast, By Product
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. Australia Urinalysis Market
- 7.4.8.1. Market Size and Forecast, By Product
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. India Urinalysis Market
- 7.4.9.1. Market Size and Forecast, By Product
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Urinalysis Market
- 7.4.10.1. Market Size and Forecast, By Product
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Urinalysis Market
- 7.4.11.1. Market Size and Forecast, By Product
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Urinalysis Market
- 7.5.6.1. Market Size and Forecast, By Product
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Urinalysis Market
- 7.5.7.1. Market Size and Forecast, By Product
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Urinalysis Market
- 7.5.8.1. Market Size and Forecast, By Product
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Urinalysis Market
- 7.5.9.1. Market Size and Forecast, By Product
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Sysmex Corporation
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Siemens Healthcare GmbH
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. ACON Laboratories, Inc.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Arkray Inc
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. F. Hoffmann-La Roche Ltd.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Quidel Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Thermo Fisher Scientific Inc.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Bio-Rad Laboratories, Inc.
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 5. URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. URINALYSIS MARKET FOR PREGNANCY FERTILITY TESTING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. GLOBAL URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 8. URINALYSIS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. URINALYSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. URINALYSIS MARKET FOR HOME CARE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. URINALYSIS MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. NORTH AMERICA URINALYSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 13. NORTH AMERICA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 14. NORTH AMERICA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 16. U.S. URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 17. U.S. URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 18. U.S. URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. CANADA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 20. CANADA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. MEXICO URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 23. MEXICO URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 24. MEXICO URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. EUROPE URINALYSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 26. EUROPE URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 27. EUROPE URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. GERMANY URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 30. GERMANY URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 31. GERMANY URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. FRANCE URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 35. UK URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 36. UK URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 37. UK URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 38. ITALY URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. SPAIN URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. REST OF EUROPE URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 45. REST OF EUROPE URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 46. REST OF EUROPE URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. ASIA-PACIFIC URINALYSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 48. ASIA-PACIFIC URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 49. ASIA-PACIFIC URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. JAPAN URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 52. JAPAN URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 53. JAPAN URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. CHINA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. AUSTRALIA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 58. AUSTRALIA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 59. AUSTRALIA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. INDIA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 62. INDIA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. SOUTH KOREA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. REST OF ASIA-PACIFIC URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 67. REST OF ASIA-PACIFIC URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 68. REST OF ASIA-PACIFIC URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 69. LAMEA URINALYSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 70. LAMEA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 71. LAMEA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. BRAZIL URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 74. BRAZIL URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 75. BRAZIL URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 76. SAUDI ARABIA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 77. SAUDI ARABIA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 78. SAUDI ARABIA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 79. SOUTH AFRICA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 82. REST OF LAMEA URINALYSIS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 83. REST OF LAMEA URINALYSIS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 84. REST OF LAMEA URINALYSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 85. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 86. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 87. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 88. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 89. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. SYSMEX CORPORATION: KEY EXECUTIVES
- TABLE 91. SYSMEX CORPORATION: COMPANY SNAPSHOT
- TABLE 92. SYSMEX CORPORATION: OPERATING SEGMENTS
- TABLE 93. SYSMEX CORPORATION: PRODUCT PORTFOLIO
- TABLE 94. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. SIEMENS HEALTHCARE GMBH: KEY EXECUTIVES
- TABLE 96. SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT
- TABLE 97. SIEMENS HEALTHCARE GMBH: OPERATING SEGMENTS
- TABLE 98. SIEMENS HEALTHCARE GMBH: PRODUCT PORTFOLIO
- TABLE 99. SIEMENS HEALTHCARE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. ACON LABORATORIES, INC.: KEY EXECUTIVES
- TABLE 101. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 102. ACON LABORATORIES, INC.: OPERATING SEGMENTS
- TABLE 103. ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
- TABLE 104. ACON LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. ARKRAY INC: KEY EXECUTIVES
- TABLE 106. ARKRAY INC: COMPANY SNAPSHOT
- TABLE 107. ARKRAY INC: OPERATING SEGMENTS
- TABLE 108. ARKRAY INC: PRODUCT PORTFOLIO
- TABLE 109. ARKRAY INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: KEY EXECUTIVES
- TABLE 111. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: COMPANY SNAPSHOT
- TABLE 112. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: OPERATING SEGMENTS
- TABLE 113. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: PRODUCT PORTFOLIO
- TABLE 114. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 116. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 117. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
- TABLE 118. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 119. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 120. QUIDEL CORPORATION: KEY EXECUTIVES
- TABLE 121. QUIDEL CORPORATION: COMPANY SNAPSHOT
- TABLE 122. QUIDEL CORPORATION: OPERATING SEGMENTS
- TABLE 123. QUIDEL CORPORATION: PRODUCT PORTFOLIO
- TABLE 124. QUIDEL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 125. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
- TABLE 126. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
- TABLE 127. THERMO FISHER SCIENTIFIC INC. : OPERATING SEGMENTS
- TABLE 128. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
- TABLE 129. THERMO FISHER SCIENTIFIC INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 130. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
- TABLE 131. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
- TABLE 132. BIO-RAD LABORATORIES, INC. : OPERATING SEGMENTS
- TABLE 133. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
- TABLE 134. BIO-RAD LABORATORIES, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL URINALYSIS MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF URINALYSIS MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN URINALYSIS MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALURINALYSIS MARKET
- FIGURE 10. GLOBAL URINALYSIS MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL URINALYSIS MARKET SEGMENTATION, BY APPLICATION
- FIGURE 14. URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. URINALYSIS MARKET FOR PREGNANCY FERTILITY TESTING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. GLOBAL URINALYSIS MARKET SEGMENTATION, BY END USER
- FIGURE 17. URINALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. URINALYSIS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. URINALYSIS MARKET FOR HOME CARE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 24. COMPETITIVE DASHBOARD
- FIGURE 25. COMPETITIVE HEATMAP: URINALYSIS MARKET
- FIGURE 26. TOP PLAYER POSITIONING, 2023
- FIGURE 27. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 28. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. SYSMEX CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. SIEMENS HEALTHCARE GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. SIEMENS HEALTHCARE GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. SIEMENS HEALTHCARE GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. ACON LABORATORIES, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. ACON LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. ACON LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. ARKRAY INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. ARKRAY INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. ARKRAY INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. QUIDEL CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. QUIDEL CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. QUIDEL CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. THERMO FISHER SCIENTIFIC INC. : NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. BIO-RAD LABORATORIES, INC. : NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook